AI-Powered ServiceNow IRM/GRC for Pharma: Staying Inspection-Ready with GxP and 21 CFR Part 11
Few industries face compliance demands as exacting as pharmaceuticals and life sciences. GxP, FDA 21 CFR Part 11, EU Annex 11, data-integrity (ALCOA+) expectations, pharma-covigilance rules, supplier qualification and privacy laws all apply at once - often across dozens of countries and contract partners. A single gap can mean a warning letter, a delayed launch or a disrupted supply of critical medicines.
AI-powered ServiceNow IRM/GRC gives pharma companies a modern, validated way to manage that complexity.
Compliance challenges in pharma and life sciences
Low control visibility across R&D, manufacturing, quality and commercial functions
Inspection readiness that depends on heroic, last-minute evidence gathering
Third-party exposure from CROs, CMOs, API suppliers and distributors
Constant regulatory change across FDA, EMA and other health authorities
Validated systems — any GRC platform must itself meet computer system validation expectations
How ServiceNow IRM, enhanced with AI, helps
Unified control framework: map GxP, 21 CFR Part 11, Annex 11, SOX, GDPR and HIPAA requirements to a single, de-duplicated control library
Now Assist for IRM: AI summaries of issues, deviations and risks, plus control-effectiveness reviews that surface weak controls before inspectors do
Regulatory change management: AI-assisted impact analysis that highlights which SOPs and policies are affected by a new guidance or regulation
Third-party risk management: automated supplier assessments, AI-assisted review of supplier documents and continuous monitoring of CMO and CRO risk
Audit management and evidence collection: a complete, time-stamped trail ready for internal audits and health-authority inspections
Benefits for pharma organisations
Always inspection-ready with continuous, rather than periodic, evidence
Higher control visibility across sites, functions and partners
Faster remediation through AI-guided issue resolution workflows
Reduced compliance cost by testing once and complying with many frameworks
Safer AI adoption — govern AI use in R&D and manufacturing on the same platform
A real-world result
For a Fortune 100 pharmaceutical company, REDE Consulting delivered a ServiceNow IRM deployment in 16 weeks that raised control visibility from 28% to more than 90%. Our consultants combine ServiceNow certifications with GxP and audit credentials, so validation and regulatory needs are built in from day one.
Where to begin
Start with a GxP-focused maturity assessment, then prioritize the highest-value use cases — typically supplier risk, audit management or regulatory change — using pre-built pharma control libraries to accelerate go-live.
About REDE Consulting
REDE Consulting helps regulated enterprises across the USA, Europe and South-East Asia turn risk and compliance into a strategic advantage. We combine deep ServiceNow IRM/GRC expertise with Databricks Data + AI to create one connected risk intelligence layer for Finance, Pharma & Life Sciences, and Healthcare.
Our services include:
Strategic advisory & regulatory intelligence — maturity assessments, gap analysis and roadmaps
ServiceNow IRM/GRC implementation — risk, policy, audit, third-party risk, resilience and automated control testing
AI-powered development & data-led governance — custom ServiceNow builds, Databricks pipelines, predictive risk analytics and AI governance
Managed services & continuous governance — continuous monitoring, optimisation and remote expert pods
With certified consultants (ServiceNow, CISA, CRISC, CISM and GxP), pre-built accelerators and coverage of 150+ compliance frameworks — including DORA, NIS2, SOX, HIPAA, HITRUST, GxP, 21 CFR Part 11 and PCI DSS — we help global clients go live 40–60% faster.
Connect with our team
Ready to explore what AI-powered risk and data intelligence can do for your organisation? Email us at info@rede-consulting.com or visit www.rede-consulting.com to book a conversation with our experts.
Comments